vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Urban Edge Properties (UE). Click either name above to swap in a different company.

Urban Edge Properties is the larger business by last-quarter revenue ($132.6M vs $85.1M, roughly 1.6× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 17.1%, a 5.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 12.2%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 11.6%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Urban Edge Properties is a publicly traded real estate investment trust (REIT) that owns, operates, and develops high-quality retail and mixed-use properties, primarily located in densely populated urban and suburban markets across the United States. Its portfolio covers grocery-anchored shopping centers, lifestyle outlets, and community-focused commercial assets.

FDMT vs UE — Head-to-Head

Bigger by revenue
UE
UE
1.6× larger
UE
$132.6M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508887.8% gap
FDMT
8508900.0%
12.2%
UE
Higher net margin
FDMT
FDMT
5.7% more per $
FDMT
22.8%
17.1%
UE
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
11.6%
UE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FDMT
FDMT
UE
UE
Revenue
$85.1M
$132.6M
Net Profit
$19.4M
$22.6M
Gross Margin
Operating Margin
17.3%
Net Margin
22.8%
17.1%
Revenue YoY
8508900.0%
12.2%
Net Profit YoY
139.1%
-6.7%
EPS (diluted)
$0.43
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
UE
UE
Q1 26
$132.6M
Q4 25
$85.1M
$119.6M
Q3 25
$90.0K
$120.1M
Q2 25
$15.0K
$114.1M
Q1 25
$14.0K
$118.2M
Q4 24
$1.0K
$116.4M
Q3 24
$3.0K
$112.4M
Q2 24
$5.0K
$106.5M
Net Profit
FDMT
FDMT
UE
UE
Q1 26
$22.6M
Q4 25
$19.4M
$12.4M
Q3 25
$-56.9M
$14.9M
Q2 25
$-54.7M
$58.0M
Q1 25
$-48.0M
$8.2M
Q4 24
$30.1M
Q3 24
$-43.8M
$9.1M
Q2 24
$-35.0M
$30.8M
Operating Margin
FDMT
FDMT
UE
UE
Q1 26
Q4 25
17.3%
11.3%
Q3 25
-67983.3%
13.4%
Q2 25
-396373.3%
53.9%
Q1 25
-383007.1%
7.6%
Q4 24
27.6%
Q3 24
-1704400.0%
8.9%
Q2 24
-849120.0%
30.6%
Net Margin
FDMT
FDMT
UE
UE
Q1 26
17.1%
Q4 25
22.8%
10.4%
Q3 25
-63195.6%
12.4%
Q2 25
-364386.7%
50.8%
Q1 25
-342657.1%
6.9%
Q4 24
25.9%
Q3 24
-1461433.3%
8.1%
Q2 24
-699060.0%
28.9%
EPS (diluted)
FDMT
FDMT
UE
UE
Q1 26
$0.18
Q4 25
$0.43
$0.09
Q3 25
$-1.01
$0.12
Q2 25
$-0.98
$0.46
Q1 25
$-0.86
$0.07
Q4 24
$0.25
Q3 24
$-0.79
$0.07
Q2 24
$-0.63
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
UE
UE
Cash + ST InvestmentsLiquidity on hand
$402.7M
$50.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$505.7M
$1.4B
Total Assets
$566.7M
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
UE
UE
Q1 26
$50.0M
Q4 25
$402.7M
$48.9M
Q3 25
$305.1M
$77.8M
Q2 25
$293.2M
$53.0M
Q1 25
$321.4M
$48.0M
Q4 24
$424.9M
$41.4M
Q3 24
$501.9M
$67.9M
Q2 24
$541.9M
$78.6M
Stockholders' Equity
FDMT
FDMT
UE
UE
Q1 26
$1.4B
Q4 25
$505.7M
$1.4B
Q3 25
$369.0M
$1.4B
Q2 25
$420.9M
$1.4B
Q1 25
$469.7M
$1.4B
Q4 24
$510.6M
$1.4B
Q3 24
$552.9M
$1.3B
Q2 24
$588.3M
$1.3B
Total Assets
FDMT
FDMT
UE
UE
Q1 26
$3.4B
Q4 25
$566.7M
$3.3B
Q3 25
$424.0M
$3.3B
Q2 25
$473.6M
$3.3B
Q1 25
$515.7M
$3.3B
Q4 24
$560.4M
$3.3B
Q3 24
$604.0M
$3.2B
Q2 24
$620.1M
$3.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
UE
UE
Operating Cash FlowLast quarter
$28.6M
$39.1M
Free Cash FlowOCF − Capex
$28.5M
FCF MarginFCF / Revenue
33.5%
Capex IntensityCapex / Revenue
0.1%
1.5%
Cash ConversionOCF / Net Profit
1.47×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
UE
UE
Q1 26
$39.1M
Q4 25
$28.6M
$182.7M
Q3 25
$-46.5M
$55.7M
Q2 25
$-43.4M
$43.5M
Q1 25
$-47.8M
$32.6M
Q4 24
$-134.6M
$153.2M
Q3 24
$-29.4M
$36.6M
Q2 24
$-30.2M
$41.2M
Free Cash Flow
FDMT
FDMT
UE
UE
Q1 26
Q4 25
$28.5M
$81.8M
Q3 25
$-46.6M
$26.1M
Q2 25
$-43.4M
$19.6M
Q1 25
$-48.4M
$11.9M
Q4 24
$-138.4M
$42.5M
Q3 24
$-31.2M
$12.2M
Q2 24
$-30.6M
$19.9M
FCF Margin
FDMT
FDMT
UE
UE
Q1 26
Q4 25
33.5%
68.4%
Q3 25
-51765.6%
21.7%
Q2 25
-289620.0%
17.2%
Q1 25
-345635.7%
10.0%
Q4 24
-13837100.0%
36.6%
Q3 24
-1038966.7%
10.8%
Q2 24
-611840.0%
18.6%
Capex Intensity
FDMT
FDMT
UE
UE
Q1 26
1.5%
Q4 25
0.1%
84.4%
Q3 25
101.1%
24.6%
Q2 25
440.0%
20.9%
Q1 25
4507.1%
17.5%
Q4 24
378600.0%
95.1%
Q3 24
59266.7%
21.7%
Q2 24
6980.0%
20.1%
Cash Conversion
FDMT
FDMT
UE
UE
Q1 26
1.73×
Q4 25
1.47×
14.71×
Q3 25
3.73×
Q2 25
0.75×
Q1 25
3.97×
Q4 24
5.09×
Q3 24
4.03×
Q2 24
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FDMT
FDMT

Segment breakdown not available.

UE
UE

Rental revenue$124.2M94%
Other$8.4M6%

Related Comparisons